Sorrento Therapeutics, Inc.
SRNE
SRNE was delisted on the 22nd of February, 2023.
186 hedge funds and large institutions have $386M invested in Sorrento Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 105 funds opening new positions, 55 increasing their positions, 19 reducing their positions, and 11 closing their positions.
855% more first-time investments, than exits
New positions opened: 105 | Existing positions closed: 11
519% more capital invested
Capital invested by funds: $62.4M → $386M (+$324M)
189% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 19
102% more funds holding
Funds holding: 92 → 186 (+94)
71% more call options, than puts
Call options by funds: $46M | Put options by funds: $26.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$29.4M |
| 2 |
BlackRock
New York
|
+$14.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$6.39M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$5.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$1.59M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.1M |
| 3 |
Goldman Sachs
New York
|
-$935K |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$313K |
| 5 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
-$279K |
SRNE Hedge Fund Activity: Q2 2020 in Review
186 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q2 2020, worth a combined $386M — up 519% from $62.4M a quarter earlier.
Buyers outnumbered sellers: 105 funds opened new SRNE positions and 11 closed out — a net gain of 94 holders — while 55 added to existing stakes and 19 trimmed.
The largest buyer was State Street, adding an estimated $29.4M. The largest seller was AllianceBernstein, cutting an estimated $1.59M.
- 186 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q2 2020, up from 92 in Q1 2020.
- Funds reported $386M of Sorrento Therapeutics, Inc. stock for Q2 2020, up 519% quarter-over-quarter.
- 105 funds opened new Sorrento Therapeutics, Inc. positions in Q2 2020 and 11 closed out, a net change of +94 holders.
- The largest Sorrento Therapeutics, Inc. buyer in Q2 2020 was State Street, an estimated $29.4M added.
- The largest Sorrento Therapeutics, Inc. seller in Q2 2020 was AllianceBernstein, an estimated $1.59M sold.
Based on aggregated 13F filings for Q2 2020.